Emerald Mutual Fund Advisers Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-230
Closed -$175K 209
2025
Q3
$175K Sell
230
-108
-32% -$80.4K 0.01% 196
2025
Q2
$263K Sell
338
-86
-20% -$66.8K 0.02% 176
2025
Q1
$350K Sell
424
-48
-10% -$39.9K 0.02% 165
2024
Q4
$364K Sell
472
-90
-16% -$74.5K 0.02% 166
2024
Q3
$498K Buy
562
+244
+77% +$219K 0.03% 161
2024
Q2
$288K Buy
318
+106
+50% +$84.8K 0.02% 175
2024
Q1
$165K Sell
212
-7
-3% -$4.98K 0.01% 197
2023
Q4
$128K Buy
+219
New +$128K 0.01% 230
2023
Q1
Sell
-258
Closed -$94.4K 245
2022
Q4
$94.4K Sell
258
-23
-8% -$8.15K 0.01% 204
2022
Q3
$91K Sell
281
-17
-6% -$5.39K 0.01% 208
2022
Q2
$97K Buy
+298
New +$89.5K 0.01% 201

Other funds holding LLY

Emerald Mutual Fund Advisers Trust's LLY Position: Q4 2025 in Review

Emerald Mutual Fund Advisers Trust sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 230 shares — an estimated $175K sold.

Emerald Mutual Fund Advisers Trust first reported a position in LLY in Q2 2022 and held it in 11 quarters. The position peaked at $498K in Q3 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Emerald Mutual Fund Advisers Trust reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 230 Eli Lilly shares in Q4 2025, an estimated $175K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Eli Lilly in Q2 2022 and held it in 11 quarters.
  • Emerald Mutual Fund Advisers Trust's Eli Lilly position peaked at $498K in Q3 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2025, filed 9 Feb 2026.